Monday, September 20, 2021

Pfizer’s mix of science and grit alters the course of COVID-19

Angela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how having a deep company heritage can help.
Pfizer’s mix of science and grit alters the course of COVID-19

No comments:

Post a Comment